Efficacy and safety of bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized trials

被引：0
|
作者：
Jiang, Long [1 ]
Cheng, Xiaoshu [1 ]
Yang, Renqiang [1 ]
Hu, Lijuan [2 ]
Fan, Yingli [1 ]
Zhan, Rui [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Nanchang, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 136
页数：2
相关论文
共 50 条
  • [31] Mortality of patients treated with bivalirudin compared to heparin plus glycoprotein IIb/IIIa inhibitors after clopidogrel pre-treatment: a meta-analysis from randomized trials
    Stone, G. W.
    Pocock, S. J.
    Moses, J. W.
    Gersh, B. J.
    Witzenbichler, B.
    Guagliumi, G.
    White, H. D.
    Lansky, A. J.
    Dangas, G. D.
    Mehran, R.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 908 - 908
  • [32] Superior safety with similar efficacy of bivalirudin over glycoprotein IIb/IIIa inhibitors in primary percutaneous intervention
    Kodumuri, V.
    Singh, P.
    Singh, M.
    Sethi, A.
    Kovacs, D.
    Khosla, S.
    Arora, R.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 656 - 656
  • [33] Bivalirudin versus heparin during percutaneous coronary intervention: a meta-analysis of randomized trials
    Cassese, Salvatore
    Byrne, Robert
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [34] Comparison of heparin, bivalirudin, and different glycoprotein IIb/IIIa inhibitor regimens for anticoagulation during percutaneous coronary intervention: A network meta-analysis
    Lipinski, Michael J.
    Lee, Regina C.
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Garcia-Garcia, Hector M.
    Pichard, Augusto D.
    Satler, Lowell F.
    Waksman, Ron
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2016, 17 (08) : 535 - 545
  • [35] Clinical Outcomes of Percutaneous Coronary Intervention using Bivalirudin Versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in the NHLBI Dynamic Registry
    Iqbal, Sohah N.
    Selzer, Faith
    Feit, Frederick
    Glaser, Ruchira
    Mulukutla, Suresh R.
    Wilensky, Robert L.
    Abbott, J. Dawn
    Williams, David O.
    Slater, James
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A66 - A67
  • [36] A Comparison of Intracoronary with Intravenous Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
    Fu, Gang
    Jia, Lei
    Zhao, Xin
    Wang, Yibo
    Chen, Xiaohui
    Yang, Yang
    Lu, Na
    Zhao, Wei
    Hui, Rutai
    Zheng, Yang
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2012, 25 (03) : 223 - 234
  • [37] Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Elbadawi, Ayman
    Elgendy, Islam Y.
    Megaly, Michael
    Ha, Le Dung
    Mahmoud, Karim
    Alotaki, Erfan
    Ogunbayo, Gbolahan O.
    Baig, Basarat
    Abuzaid, A. S.
    Saad, Marwan
    Depta, Jeremiah P.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (07): : 1055 - 1061
  • [38] Glycoprotein IIb/IIIa Inhibitors in Patients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention
    Anderson, Joe R.
    Riding, Dan
    [J]. CARDIOLOGY IN REVIEW, 2008, 16 (04) : 213 - 218
  • [39] Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
    Vaduganathan, Muthiah
    Harrington, Robert A.
    Stone, Gregg W.
    Deliargyris, Efthymios N.
    Steg, Ph. Gabriel
    Gibson, C. Michael
    Hamm, Christian W.
    Price, Matthew J.
    Menozzi, Alberto
    Prats, Jayne
    Elkin, Steven
    Mahaffey, Kenneth W.
    White, Harvey D.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (02) : 176 - 185
  • [40] Safety of switching glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention
    Grabarczyk, MA
    Staton, S
    Applegate, RJ
    Sacrinty, M
    Baki, TT
    Gandhi, SK
    Little, WC
    Kutcher, MA
    Sane, DC
    Forest, W
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 37A - 37A
12345